⌕
Adlai Nortye Group· ANL · NasdaqHeld by 4 US ETFsOpen stock report

ETFs That Hold Adlai Nortye Group (ANL)

Like Adlai Nortye Group but not the single-stock risk? Find every fund that holds it, ranked by how much. Flip the lens to find the cleanest way to own it, the most diversified wrapper, or (in avoidance mode) which of your funds sneak it in.

Lens
the cleanest, most concentrated way to own it
Embeds on the ANL stock report“ETF Exposure” card · top 5 by weight
BBC
0.8%
ANL weight
CANC
0.5%
ANL weight
EWX
0.1%
ANL weight
GXC
0.0%
ANL weight
Issuer
FundIssuerANL weight · shared scaleExpenseAUM
BBC
Virtus Biotech Clinical Trials ETF
Virtus
0.8%
0.65%$39.1M›
CANC
Tema Oncology ETF
Tema
0.5%
0.99%$210.8M›
EWX
State Street SPDR S&P Emerging Markets Small Cap ETF
SPDR
0.1%
0.65%$634.5M›
GXC
State Street SPDR S&P China ETF
SPDR
0.0%
0.59%$426.9M›
4 US-listed holders · fee and assets from the nightly fund profilePage 1 / 1

Reverse lookup across 5 global listings · ranked by portfolio weight. Weights are the latest holdings each fund reported, refreshed in the background, so the weights and the holder, issuer and listing counts this page prints can all shift between two loads. Fee and assets are joined for every holder from the nightly fund profile, not read live. Exposure data is decision-support, not a recommendation · Not investment advice.

How many ETFs hold Adlai Nortye Group (ANL)?

Adlai Nortye Group (ANL) is held by 4 US-listed ETFs, in each fund's latest reported holdings.

Which ETF holds the most Adlai Nortye Group?

Of the US-listed ETFs in our fund data, Virtus Biotech Clinical Trials ETF (BBC) holds Adlai Nortye Group at the largest portfolio weight, in each fund's latest reported holdings.

What ETFs hold Adlai Nortye Group?

By portfolio weight, the US-listed ETFs that hold the most Adlai Nortye Group are BBC, CANC, EWX and GXC, in each fund's latest reported holdings.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.